158 related articles for article (PubMed ID: 15164304)
1. Apoptosis in human uterine leiomyomas.
Martel KM; Ko AC; Christman GM; Stribley JM
Semin Reprod Med; 2004 May; 22(2):91-103. PubMed ID: 15164304
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis, cellular proliferation and expression of p53 in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause.
Wu X; Blanck A; Olovsson M; Möller B; Favini R; Lindblom B
Acta Obstet Gynecol Scand; 2000 May; 79(5):397-404. PubMed ID: 10830768
[TBL] [Abstract][Full Text] [Related]
3. Cell proliferation and apoptosis in human uterine leiomyomas and myometria.
Dixon D; Flake GP; Moore AB; He H; Haseman JK; Risinger JI; Lancaster JM; Berchuck A; Barrett JC; Robboy SJ
Virchows Arch; 2002 Jul; 441(1):53-62. PubMed ID: 12111201
[TBL] [Abstract][Full Text] [Related]
4. Fas and its ligand, caspases, and bcl-2 expression in gonadotropin-releasing hormone agonist-treated uterine leiomyoma.
Huang SC; Tang MJ; Hsu KF; Cheng YM; Chou CY
J Clin Endocrinol Metab; 2002 Oct; 87(10):4580-6. PubMed ID: 12364438
[TBL] [Abstract][Full Text] [Related]
5. Growth factors and cytokines in uterine leiomyomas.
Andersen J
Semin Reprod Endocrinol; 1996 Aug; 14(3):269-82. PubMed ID: 8885057
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis.
Hoffman PJ; Milliken DB; Gregg LC; Davis RR; Gregg JP
Fertil Steril; 2004 Sep; 82(3):639-49. PubMed ID: 15374708
[TBL] [Abstract][Full Text] [Related]
7. Factors in fibroid growth.
Andersen J
Baillieres Clin Obstet Gynaecol; 1998 Jun; 12(2):225-43. PubMed ID: 10023420
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice.
Al-Hendy A; Lee EJ; Wang HQ; Copland JA
Am J Obstet Gynecol; 2004 Nov; 191(5):1621-31. PubMed ID: 15547533
[TBL] [Abstract][Full Text] [Related]
9. [Expression of bcl-2 protein in uterine leiomyomas and normal myometrium].
Zhang ZL; Zhang Y; Xu BQ
Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):363-5. PubMed ID: 12536738
[TBL] [Abstract][Full Text] [Related]
10. Lessons from pregnancy and parturition: uterine leiomyomas result from discordant differentiation and dedifferentiation responses in smooth muscle cells.
Cesen-Cummings K; Walker CL; Davis BJ
Med Hypotheses; 2000 Dec; 55(6):485-90. PubMed ID: 11090295
[TBL] [Abstract][Full Text] [Related]
11. Soluble Fas receptor and soluble Fas ligand in the serum of women with uterine tumors.
Kondera-Anasz Z; Mielczarek-Palacz A; Sikora J
Apoptosis; 2005 Oct; 10(5):1143-9. PubMed ID: 16151647
[TBL] [Abstract][Full Text] [Related]
12. Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines.
Swartz CD; Afshari CA; Yu L; Hall KE; Dixon D
Mol Hum Reprod; 2005 Jun; 11(6):441-50. PubMed ID: 15879465
[TBL] [Abstract][Full Text] [Related]
13. The chemopreventive agents 4-HPR and DFMO inhibit growth and induce apoptosis in uterine leiomyomas.
Broaddus RR; Xie S; Hsu CJ; Wang J; Zhang S; Zou C
Am J Obstet Gynecol; 2004 Mar; 190(3):686-92. PubMed ID: 15042000
[TBL] [Abstract][Full Text] [Related]
14. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups.
Al-Hendy A; Salama SA
J Soc Gynecol Investig; 2006 Feb; 13(2):136-44. PubMed ID: 16443508
[TBL] [Abstract][Full Text] [Related]
15. Interferon-inducible genes, TNF-related apoptosis-inducing ligand (TRAIL) and interferon inducible protein 27 (IFI27) are negatively regulated in leiomyomas: implications for a role of the interferon pathway in leiomyoma development.
Mihalich A; Viganò P; Gentilini D; Borghi MO; Vignali M; Busacca M; Di Blasio A
Gynecol Endocrinol; 2012 Mar; 28(3):216-9. PubMed ID: 22320196
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
[TBL] [Abstract][Full Text] [Related]
17. The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth.
Shushan A; Rojansky N; Laufer N; Klein BY; Shlomai Z; Levitzki R; Hartzstark Z; Ben-Bassat H
Hum Reprod; 2004 Sep; 19(9):1957-67. PubMed ID: 15205403
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative and proapoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women.
Palomba S; Orio F; Russo T; Falbo A; Tolino A; Lombardi G; Cimini V; Zullo F
Fertil Steril; 2005 Jul; 84(1):154-61. PubMed ID: 16009171
[TBL] [Abstract][Full Text] [Related]
19. Sex steroidal regulation of uterine leiomyoma growth and apoptosis.
Maruo T; Ohara N; Wang J; Matsuo H
Hum Reprod Update; 2004; 10(3):207-20. PubMed ID: 15140868
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells.
Ohara N; Morikawa A; Chen W; Wang J; DeManno DA; Chwalisz K; Maruo T
Reprod Sci; 2007 Dec; 14(8 Suppl):20-7. PubMed ID: 18089606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
